-
-
-
-
7 . Periodical
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
- 저자
- by Turkova, Anna; Waalewijn, Hylke; Chan, Man K; Bollen, Pauline D J; Bwakura-Dangarembizi, Mutsa F, et al.
- 소스
- The Lancet HIV; September 2022, Vol. 9 Issue: 9 pe627-e637, 11p